Concise synthesis and antiangiogenic activity of artemisinin-glycolipid hybrids on chorioallantoic membranes

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6858-6860

  Ricci, Jérémy ^a   Park, Jeehyun ^a   Chung, Won Yoon ^b   Park, Kwang Kyun ^b   Jung, Mankil ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

Author keywords

Antiangiogenesis; Anticancer activity; Artemisinin; Glycolipid; Non acetal type

Indexed keywords

ANGIOGENESIS INHIBITOR; ARTEMISININ; ARTEMISININ GLYCOLIPID HYBRID PROTEIN; CARBOXYMETHYLDEOXOARTEMISININ; FUMAGILLIN; GLYCOLIPID; HYBRID PROTEIN; THALIDOMIDE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CHORIOALLANTOIS; CLINICAL EVALUATION; CROSS COUPLING REACTION; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VIVO STUDY; NONHUMAN;

ANGIOGENESIS INHIBITORS; ANIMALS; ARTEMISININS; CHICK EMBRYO; CHORION; GLYCOLIPIDS;

EID: 77958052303     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.08.013     Document Type: Article

References (22)

1. A.M. Ali, M. Toi, and T. Ueno Curr. Mol. Med. 9 2009 954
2. D.L. Klayman Science (Washington DC) 228 1985 1049
3. M. Jung, S. Lee, J. Ham, K. Lee, H. Kim, and S.K. Kim J. Med. Chem. 46 2003 987
4. M. Jung, and S. Lee Bioorg. Med. Chem. Lett. 8 1998 1003
5. J.A. Willoughby, S.N. Sundar, M. Cheung, A.S. Tin, J. Modiano, and G.L. Firestone J. Biol. Chem. 284 2009 2203
6. M. Jung, N. Park, H.-I. Moon, Y. Lee, W.-Y. Chung, and K.-K. Park Bioorg. Med. Chem. Lett. 19 2009 6303
7. H.-H. Chen, H.-J. Zhou, and X. Fang Pharmacol. Res. 48 2003 231
8. H.-h. Chen, L.-L. You, and S.-b. Li Cancer Lett. 211 2004 163
9. S. Oh, I.H. Jeong, C.M. Ahn, W.-S. Shin, and S. Lee Bioorg. Med. Chem. 12 2004 3783
10. R. Dell'Eva, U. Pfeffer, R. Vene, L. Anfosso, A. Forlani, A. Albini, and T. Efferth Biochem. Pharmacol. 68 2004 2359
11. H.-H. Chen, H.-J. Zhou, W.-Q. Wang, and G.-D. Wu Cancer Chemother. Pharmacol. 53 2004 423
12. M. Jung, J. Tak, W.-Y. Chung, and K.-K. Park Bioorg. Med. Chem. Lett. 16 5 2006 1227
13. K. Matsubara, H. Matsumoto, Y. Mizushina, M. Mori, N. Nakajima, M. Fuchigami, H. Yoshida, and T. Hada Oncol. Rep. 14 2005 157
14. M. Miura, I. Sakimoto, K. Ohta, F. Sugawara, and K. Sakaguchi Anti-Cancer Drugs 18 2007 1
15. P.-Y. Jeong, M. Jung, Y.-H. Yim, H. Kim, M. Park, E. Hong, W. Lee, H. Kim Young, K. Kim, and Y.-K. Paik Nature 433 2005 541
16. M. Jung, Y. Lee, H.-I. Moon, Y. Jung, H. Jung, and M. Oh Eur. J. Med. Chem. 44 2009 3120
17. L.K. Gediya, and V.C.O. Njar Expert Opin. Drug Disc. 4 2009 1099
18. J. Chadwick, A.E. Mercer, B.K. Park, R. Cosstick, and P.M. O'Neill Bioorg. Med. Chem. 17 2009 1325
19. M. Jung, D. Yu, D. Bustos, H.N. ElSohly, and J.D. McChesney Bioorg. Med. Chem. Lett. 1 1991 741
20. M. Jung, A.C.C. Freitas, J.D. McChesney, and H.N. ElSohly Heterocycles 39 1994 23
21. C.A. Staton, M.W.R. Reed, and N.J. Brown Int. J. Exp. Pathol. 90 3 2009 195
22. Tropical Disease Research Progress 1995-1996, Thirteenth Program Report of UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (WHO), World Health Organization, 1997; p 51.